L. Kanz

发表

Risk for cytomegalovirus disease in patients receiving polymerase chain reaction-based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modality.

H. Einsele, L. Kanz, W. Brugger, 2001, Blood.

Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo.

S. Heimfeld, L. Kanz, W. Brugger, 1995, The New England journal of medicine.

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.

L. Kanz, W. Brugger, R. Mertelsmann, 1992, Blood.

The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.

S. Rafii, L. Kanz, R. Möhle, 1998, Blood.

Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.

L. Kanz, B. Meister, W. Brugger, 2000, Experimental hematology.

Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin.

L. Kanz, R. Möhle, W. Brugger, 2000, Experimental hematology.

Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells.

D. Birnbaum, L. Kanz, C. Hannum, 1996, Leukemia.

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.

L. Kanz, W. Brugger, P. Brossart, 2000, Blood.

Treatment of older patients with mantle-cell lymphoma.

W. Klapper, E. Hoster, B. Coiffier, 2012, The New England journal of medicine.

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.

C. Bokemeyer, L. Kanz, M. Kuczyk, 1998, British Journal of Cancer.

Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy.

C. Bokemeyer, L. Kanz, L. Looijenga, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.

L. Kanz, W. Brugger, R. Engelhardt, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

HHV8 associated Kaposi's sarcoma during triple immunosuppressive treatment with cyclosporin A, azathioprine, and prednisolone for ocular Behçet's disease and complete remission of both disorders with interferon α

L. Kanz, R. Kandolf, M. Zierhut, 2001, Annals of the rheumatic diseases.

Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.

H. Rammensee, S. Stevanović, L. Kanz, 1999, Blood.

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

K. Spiekermann, M. Pfreundschuh, L. Kanz, 2015, Leukemia.

Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47.

A. Ullrich, L. Kanz, W. Brugger, 1999, Blood.

Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini

H. Rammensee, S. Stevanović, O. Kohlbacher, 2016, Blood Cancer Journal.

Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy

H. Rammensee, S. Stevanović, L. Kanz, 2015, Leukemia.

Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma.

C D Claussen, C. Claussen, C. Bokemeyer, 2001, Oncology reports.

Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study.

A. Ganser, L. Kanz, F. Herrmann, 1992, Blood.

Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes

J. Gribben, L. Kanz, M. Labopin, 2016, Bone Marrow Transplantation.

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.

L. Kanz, W. Brugger, R. Mertelsmann, 1994, Blood.

Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.

S. Heimfeld, L. Kanz, W. Brugger, 1994, Blood.

Functional and phenotypic characterization of cord blood and bone marrow subsets expressing FLT3 (CD135) receptor tyrosine kinase.

A. Zannettino, D. Birnbaum, A. Ullrich, 1997, Blood.

Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)

L. Kanz, R. Möhle, F. Bautz, 1999, Leukemia.

Dendritic cells in cancer vaccines.

L. Kanz, W. Brugger, P. Brossart, 2001, Experimental hematology.

Relapse of autoimmune diseases after autologous T cell depleted stem cell transplantation may be triggered by T cells recently emigrated from the thymus.

J. Löffler, T. Daikeler, S. Koch, 2005, Annals of the rheumatic diseases.

Relapse of autoimmune diseases after autologous T cell depleted stem cell transplantation may be triggered by T cells recently emigrated from the thymus

T. Daikeler, S. Koch, L. Lochmann, 2005 .

Relapse of autoimmune diseases after autologous T cell depleted stem cell transplantation may be triggered by T cells recently emigrated from the thymus

J. Löffler, T. Daikeler, S. Koch, 2005 .

First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.

C. Meisner, C. Bokemeyer, L. Kanz, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of brain metastases in patients with testicular cancer.

C. Bokemeyer, L. Kanz, B. Metzner, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.